Status:
COMPLETED
Relationship Between Normal-weight Central Obesity and Obstructive Sleep Apnea
Lead Sponsor:
St. Anne's University Hospital Brno, Czech Republic
Conditions:
Sleep Disorder
Body Fat Distribution
Eligibility:
All Genders
25-65 years
Brief Summary
Comparison of the prevalence of obstructive sleep apnea (OSA), measured by polysomnography in normal weight patients with central obesity by body mass index (BMI) and waist hip ratio (WHR), with norma...
Detailed Description
Body composition (the distribution of adipose tissue) appears to be a risk factor for the prevalence of obstructive form of sleep apnea. The investigators expect a higher prevalence of this serious sl...
Eligibility Criteria
Inclusion
- Inclusion Criteria central obesity group:
- BMI 18.5 - 24.9 kg/m2 for both men and women
- WHR more than 0.9 for men and 0.85 for women
- no history of myocardial infarction, stroke, atrial fibrillation, previous diagnosis of OSA or its treatment.
- Inclusion Criteria without central obesity group:
- BMI 18.5 - 24.9 kg/m2 for men and women
- WHR selected from the lowest tertile of WHR distribution for both men and women
- Exclusion Criteria:
- acute infection
- known diagnosis of chronic renal or cardiac failure
- taking drugs that affect sleep (stimulants, hypnotics, antidepressants, antipsychotics, anxiolytics, antihistamines, corticosteroids, theophylline, anti-parkinsonic drugs, anticonvulsants, morphine-type analgetics)
Exclusion
Key Trial Info
Start Date :
May 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT04061226
Start Date
May 1 2016
End Date
July 31 2023
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Anne's University Hospital
Brno, Czechia, 65691